BTK inhibition of IgG-containing, IC-driven, FcγR-dependent functions in myeloid cells by BMS-986142 represents an important potential mechanism for the suppression of RA pathobiology and is consistent with previous studies of BTK inhibitors [5]. The gene discussed is FCGR2A; the disease is rheumatoid arthritis.